Allworth Financial’s Achieve Life Sciences ACHV Stock Holding History

Allworth Financial’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.6K	Hold	3,000	–	–	﹤0.01%	3217
2026 Q1	$8.82K	Hold	3,000	–	–	﹤0.01%	3596
2025 Q4	$14.9K	Hold	3,000	–	–	﹤0.01%	2995
2025 Q3	$9.45K	Hold	3,000	–	–	﹤0.01%	3167
2025 Q2	$6.78K	Hold	3,000	–	–	﹤0.01%	3097
2025 Q1	$7.2K	Hold	3,000	–	–	﹤0.01%	2582
2024 Q4	$9.21K	Hold	3,000	–	–	﹤0.01%	2472
2024 Q3	$14.2K	Hold	3,000	–	–	﹤0.01%	2106
2024 Q2	$13.9K	Buy	+3,000	New	+$14.5K	﹤0.01%	2084

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allworth Financial's ACHV Position: Q2 2026 in Review

Allworth Financial held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 3,000 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

Allworth Financial first reported a position in ACHV in Q2 2024 and has held it in 9 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Allworth Financial held 3,000 shares of Achieve Life Sciences worth $19.6K as of Q2 2026.
Allworth Financial left its Achieve Life Sciences share count unchanged in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3217 holding.
Allworth Financial first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 9 quarters since.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.